Growth Metrics

Travere Therapeutics (TVTX) Gross Profit (QoQ) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Travere Therapeutics 4.34 Bn 4.26 Bn 102.38 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 128.90%
Dec 31, 2025 -1,022.28%
Sep 30, 2025 -65.98%
Jun 30, 2025 62.94%
Mar 31, 2025 -4.05%
Dec 31, 2024 17.89%
Sep 30, 2024 17.71%
Jun 30, 2024 30.56%
Mar 31, 2024 -1.54%
Dec 31, 2023 13.10%
Sep 30, 2023 16.47%
Jun 30, 2023 14.96%
Mar 31, 2023 -6.07%
Dec 31, 2022 5.60%
Sep 30, 2022 1.42%
Jun 30, 2022 24.96%
Mar 31, 2022 113.54%
Dec 31, 2021 -394.28%
Sep 30, 2021 0.83%
Jun 30, 2021 15.74%
Mar 31, 2021 -6.44%
Dec 31, 2020 -2.08%
Sep 30, 2020 6.42%
Jun 30, 2020 1.16%
Mar 31, 2020 3.19%
Dec 31, 2019 4.91%
Sep 30, 2019 -1.98%
Jun 30, 2019 13.42%
Mar 31, 2019 -8.57%
Dec 31, 2018 6.56%
Sep 30, 2018 -1.46%
Jun 30, 2018 9.07%
Mar 31, 2018 -10.20%
Dec 31, 2017 4.03%
Sep 30, 2017 3.72%
Jun 30, 2017 15.47%
Mar 31, 2017 -8.89%
Dec 31, 2016 11.59%
Sep 30, 2016 0.25%
Jun 30, 2016 14.30%
Mar 31, 2016 -4.83%
Dec 31, 2015 7.98%
Sep 30, 2015 17.33%
Jun 30, 2015 37.04%
Mar 31, 2015 24.38%
Dec 31, 2014 68.67%
Sep 30, 2014 42.81%
Jun 30, 2014 20,959.04%